Large-scale testing (Phase 3)Study completedNCT00901940What this trial is testingUnderstanding the Immune Response to Meningitis VaccinesWho this might be right forMeningitisSepticemia University of Oxford 150
Not applicableStudy completedNCT02500511What this trial is testingPersistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up StudyWho this might be right forMeningococcal MeningitisMeningococcal Infections JN-International Medical Corporation 50
Testing effectiveness (Phase 2)Study completedNCT00355121What this trial is testingStudy of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®Who this might be right forMeningococcal MeningitisTetanusDiphtheria+2 more Sanofi 882
Post-approval studies (Phase 4)Study completedNCT01424644What this trial is testingA Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in AdolescentsWho this might be right forMeningococcal Meningitis Novartis 801
Large-scale testing (Phase 3)UnknownNCT03746665What this trial is testingMaternal Immunization With MenAfriVac™Who this might be right forMeningitisMeningococcal London School of Hygiene and Tropical Medicine 200
Large-scale testing (Phase 3)Study completedNCT03964012What this trial is testingStudy to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5)Who this might be right forMeningococcal Meningitis Serum Institute of India Pvt. Ltd. 1,800
Post-approval studies (Phase 4)Study completedNCT02724046What this trial is testingCiprofloxacin for the Prevention of Meningococcal MeningitisWho this might be right forMeningitis, Meningococcal Epicentre 300
Not applicableStudy completedNCT01452464What this trial is testingSafety of MenACWY-CRM Vaccination in AdolescentsWho this might be right forMeningococcal Disease Novartis Vaccines 55,397
Testing effectiveness (Phase 2)Study completedNCT01323270What this trial is testingA Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years.Who this might be right forMeningococcal VaccinerLP2086Repevax+2 more Pfizer 753
Post-approval studies (Phase 4)Study completedNCT02080559What this trial is testingInvestigating the Immune Response to 4CMenB in InfantsWho this might be right forMeningitis University of Oxford 187
Not applicableNot Yet RecruitingNCT07671014What this trial is testingMetagenomic Analysis of the Pharynx in High Risk PartnersWho this might be right forGonorrheaNeisseria GonorrheaNeisseria Meningitidis+1 more Guy's and St Thomas' NHS Foundation Trust 100
Testing effectiveness (Phase 2)Study completedNCT01897402What this trial is testingImmunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate VaccineWho this might be right forMeningococcal MeningitisMeningococcal Infections JN-International Medical Corporation 525
Large-scale testing (Phase 3)Study completedNCT03621670What this trial is testingSafety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy InfantsWho this might be right forInfections, Meningococcal GlaxoSmithKline 1,196
Large-scale testing (Phase 3)Study completedNCT02305446What this trial is testingSafety and Blood Donations in Adults Vaccinated With rMenB+OMV NZ.Who this might be right forMeningitis, Meningococcal, Serogroup B Novartis 55
Testing effectiveness (Phase 2)Study completedNCT00700635What this trial is testingDose Comparison Study of Menactra® in US ChildrenWho this might be right forMeningitisMeningococcal InfectionNeisseria Meningitidis Sanofi Pasteur, a Sanofi Company 333
Testing effectiveness (Phase 2)Study completedNCT00700713What this trial is testingAntibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26Who this might be right forMeningitisMeningococcemia Sanofi Pasteur, a Sanofi Company 181
Post-approval studies (Phase 4)Study completedNCT01430611What this trial is testingStudy of Sanofi Pasteur and Lanzhou Institute's Meningococcal (Group A and C) Polysaccharide Vaccine in ChildrenWho this might be right forMeningococcal DiseaseMeningitis Sanofi Pasteur, a Sanofi Company 666
Post-approval studies (Phase 4)Study completedNCT03493919What this trial is testingA Sourcing Study to Collect Human Blood Samples From Healthy AdultsWho this might be right forMeningitis, Meningococcal GlaxoSmithKline 1,021
Large-scale testing (Phase 3)Study completedNCT00806195What this trial is testingStudy to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy InfantsWho this might be right forMeningitisMeningococcal Infection Novartis 7,744
Early research (Phase 1)Study completedNCT04236960What this trial is testingSafety Evaluation of Meningococcal Group ACYW135 Conjugate Vaccine in 2-month to 55 Years Old Population.Who this might be right forMeningococcal Infections Walvax Biotechnology Co., Ltd. 100